|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Increase (decrease) in cash from operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories and other assets | |||||
| Accounts payable and accrued expenses | |||||
| Depreciation and amortization | |||||
| Income taxes | |||||
| Losses (gains) on sales of facilities | |||||
| Losses on retirement of debt | |||||
| Amortization of debt issuance costs and discounts | |||||
| Share-based compensation | |||||
| Other | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property and equipment | |||||
| Acquisition of hospitals and health care entities | |||||
| Sales of hospitals and health care entities | |||||
| Change in investments | |||||
| Other | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Issuances of long-term debt | |||||
| Net change in short-term borrowings and revolving credit facilities | |||||
| Repayment of long-term debt | |||||
| Distributions to noncontrolling interests | |||||
| Payment of debt issuance costs | |||||
| Payment of dividends | |||||
| Repurchase of common stock | |||||
| Other | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Interest payments | |||||
| Income tax payments, net |
Loading...
